Welcome on the Necker-Enfants Malades Institute website
Wednesday 22 of April, 2020
Simon Fillatreau, Matthieu Mahévas, Claude-Agnès Reynaud and Jean-Claude Weill have received funding from the French National Research Agency (ANR)

Do patients who recovered from COVID-19 possess an immunological memory protecting them against reinfection? If so for how long? Will it vary depending on the population considered e.g. the age of the individual, the treatment received, or the severity of the disease during the first exposure? Addressing these questions is directly relevant to public health policies dealing with confinement /deconfinement decisions as well as for vaccination design and utilization.

A team of scientists at Institut Necker-Enfants Malalades and collaborators at Hôpital Henri Mondor coordinated by Simon Fillatreau, Matthieu Mahévas, Claude-Agnès Reynaud and Jean-Claude Weill have received funding from the French National Research Agency (ANR), which established a scientific task force against COVID-19 at the national level, to examine the immunological memory that remains in affected individuals after the resolution of the infection and is the basis for the protective immunity that determines whether affected individuals can be infected twice.

Address

Notice: Undefined variable: contact_addr in /homepages/40/d483507699/htdocs/location.php on line 25
Support(s)
HRH Princess Caroline of Hanover, who through the Princess Grace Foundation, already supports medical research and anything that helps to relieve the sick children in France and around the world, has agreed to commit to our side so that our Center of Molecular medicine continues to meet the current challenges and fight diseases, and in particular the ones affecting children.

INEM - Organigramme